[Successful long-term therapy of Stewart-Bluefarb syndrome].
The Stewart-Bluefarb syndrome is defined as an unilateral angiodermatitis due to multiple arterio-venous fistules accompanied by acroangiodermatitis resembling Kaposi sarcoma (pseudo-kaposi sarcoma). The acroangiodermatitis is most common on the lower limb. It leads to ulcerated nodules with a high risk of bleeding and infection, as well as edema, pain and seldom limb hypertrophy. Curative therapy requires elimination of the arteriovenous shunts. Surgical destruction of the multiple small fistulae is a limitating factor. A better alternative is embolisation, but this approach carries the risk of ischemia and necrosis. A 32 year old female patient with Stewart-Bluefarb syndrome is presented; she has been successfully treated with embolisation on eight occasions.
Utermann
S
S
Hautklinik der Ruprecht-Karls-Universität Heidelberg.
Kahle
B
B
Petzoldt
D
D
D000328:Adult; D001165:Arteriovenous Malformations / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D004621:Embolization, Therapeutic; D004730:Endothelium, Vascular / Q000473:pathology; D005260:Female; D005528:Foot / Q000098:blood supply* / Q000473:pathology; D016523:Foot Ulcer / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D006801:Humans; D012008:Recurrence; D019233:Retreatment; D012867:Skin / Q000098:blood supply* / Q000473:pathology; D013577:Syndrome
Erfolgreiche Langzeittherapie bei Stewart-Bluefarb-Syndrom.